Several contributions look at the effect of technological M&As on the acquirer's technological performance. The knowledge-based perspective highlights the critical role that the acquirer's target's knowledge absorption plays as the main driver in enhancing post-M&A technological performance. However, absorptive capacity is a rather complex construct, which includes assimilation, utilisation and transformation of the acquired knowledge. In this paper, we focus on knowledge utilisation and investigate two factors whose effects on post-M&A technological performance have been extensively highlighted: technological relatedness and managerial experience. We contribute to the existing literature with a better understanding of the factors underlying the utilisation of the knowledge acquired in M&As. This should help managers to enhance their capacity to manage integration process post-M&As. Our results are based on a cross-sectional data set of 152 biopharmaceutical acquirers that completed at least one M&A between 2001 and 2005.

Knowledge utilisation drivers in technological M&As

De Noni I.;
2015

Abstract

Several contributions look at the effect of technological M&As on the acquirer's technological performance. The knowledge-based perspective highlights the critical role that the acquirer's target's knowledge absorption plays as the main driver in enhancing post-M&A technological performance. However, absorptive capacity is a rather complex construct, which includes assimilation, utilisation and transformation of the acquired knowledge. In this paper, we focus on knowledge utilisation and investigate two factors whose effects on post-M&A technological performance have been extensively highlighted: technological relatedness and managerial experience. We contribute to the existing literature with a better understanding of the factors underlying the utilisation of the knowledge acquired in M&As. This should help managers to enhance their capacity to manage integration process post-M&As. Our results are based on a cross-sectional data set of 152 biopharmaceutical acquirers that completed at least one M&A between 2001 and 2005.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3300941
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? ND
social impact